Investors

People are different and so is their cancer, patients should be treated individually.

Financial calendar

Date Report
25/02 2021 Year-End Report 2020
27/05 2021 Interim Report Q1 2021
27/05 2021 Annual General Meeting
26/08 2021 Interim Report Q2 2021
25/11 2021 Interim Report Q3 2021
24/02 2022 Year-End Report 2021

Upcoming events

September 15, 2021 at 15:00 (CET)

Interview with CEO Fernando Andreu (organized by Mangold) Open participation. Details provided later.

Read more

September 23, 2021

CSO Ole Thastrup will speak at the conference “Week of Health and Innovation 2021” in Odense, Denmark

Read more and Register

September 28, 2021

Redeye Medtech & Diagnostics Investor meeting

Read more

September 29, 2021

Mangold Investor Lunch

Read more

IndiTreat® supports genomic characterization of tumors with unique functional information of treatment resistance and sensitivity.